These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 17489805

  • 1. A randomized controlled trial comparing botulinum toxin A dosage in the upper extremity of children with spasticity.
    Kawamura A, Campbell K, Lam-Damji S, Fehlings D.
    Dev Med Child Neurol; 2007 May; 49(5):331-7. PubMed ID: 17489805
    [Abstract] [Full Text] [Related]

  • 2. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE, Racette BA.
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.
    Neurorehabil Neural Repair; 2009 Oct; 23(3):218-25. PubMed ID: 19106252
    [Abstract] [Full Text] [Related]

  • 4. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy.
    Fehlings D, Rang M, Glazier J, Steele C.
    J Pediatr; 2000 Sep; 137(3):331-7. PubMed ID: 10969256
    [Abstract] [Full Text] [Related]

  • 5. Repeat botulinum toxin-A injections in the upper limb of children with hemiplegia: a randomized controlled trial.
    Olesch CA, Greaves S, Imms C, Reid SM, Graham HK.
    Dev Med Child Neurol; 2010 Jan; 52(1):79-86. PubMed ID: 19583742
    [Abstract] [Full Text] [Related]

  • 6. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy.
    Lowe K, Novak I, Cusick A.
    Dev Med Child Neurol; 2007 Nov; 49(11):823-9. PubMed ID: 17979860
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 8. Low-dose/high-concentration localized botulinum toxin A improves upper limb movement and function in children with hemiplegic cerebral palsy.
    Lowe K, Novak I, Cusick A.
    Dev Med Child Neurol; 2006 Mar; 48(3):170-5. PubMed ID: 16483391
    [Abstract] [Full Text] [Related]

  • 9. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C.
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [Abstract] [Full Text] [Related]

  • 10. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.
    Wissel J, Heinen F, Schenkel A, Doll B, Ebersbach G, Müller J, Poewe W.
    Neuropediatrics; 1999 Jun; 30(3):120-4. PubMed ID: 10480205
    [Abstract] [Full Text] [Related]

  • 11. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI, Hawamdeh ZM, Al-Qudah AA.
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [Abstract] [Full Text] [Related]

  • 12. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
    Wallen M, O'Flaherty SJ, Waugh MC.
    Arch Phys Med Rehabil; 2007 Jan; 88(1):1-10. PubMed ID: 17207668
    [Abstract] [Full Text] [Related]

  • 13. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 14. Upper-limb botulinum toxin A injection and occupational therapy in children with hemiplegic cerebral palsy identified from a population register: a single-blind, randomized, controlled trial.
    Russo RN, Crotty M, Miller MD, Murchland S, Flett P, Haan E.
    Pediatrics; 2007 May; 119(5):e1149-58. PubMed ID: 17452491
    [Abstract] [Full Text] [Related]

  • 15. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H, Kotamäki A, Koivikko M, Autti-Rämö I.
    Pediatr Rehabil; 2006 May; 9(3):247-58. PubMed ID: 17050402
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC, Chuang YC, Liu JP, Chien KL, Chen YM, Chen YF.
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [Abstract] [Full Text] [Related]

  • 17. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy.
    Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P, Sanders J, D'Astous J, Aiona MD, Shriners Hospitals BTX-A Study Group.
    Dev Med Child Neurol; 2005 Sep; 47(9):620-7. PubMed ID: 16138670
    [Abstract] [Full Text] [Related]

  • 18. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia.
    Mayer NH, Whyte J, Wannstedt G, Ellis CA.
    Arch Phys Med Rehabil; 2008 May; 89(5):982-7. PubMed ID: 18452749
    [Abstract] [Full Text] [Related]

  • 19. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
    Koman LA, Smith BP, Williams R, Richardson R, Naughton M, Griffin L, Evans P.
    J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.